Transforming Cancer Care with Superior Locoregional Treatment
Our Approach
Our name says it all. Our product is injected directly into the tumor as a single treatment. It is an “in tumor” therapy.
With localized treatment directly into the tumor, our product ablates the tumor within minutes, is easy to administer, enables precise treatment area control, and provides rapid efficacy feedback for the physician all in a single outpatient treatment.
Furthermore, with our platform approach to development, our product shows promise across several indications including tumors located in prostate, liver, kidney, and lungs.
Our Value
01
Localized Effect
Treatment specificity without negative systemic or side effects
02
Ablation at a very controlled area only
03
Rapid Efficacy Feedback
Response to treatment occurs within minutes
04
Global Accessibility
No Capital Equipment
Room Temperature Stable*
05
Easy Administration & Outpatient
Low training burden
Off the shelf components
06
Minimizing HealthCare
Costs
Local anesthesia
<15 min procedure
Outpatient procedure
